WISE
Key Facts
| Invested since | 2013 |
| Based in | Berlin | Germany |
About the company
WISE Srl is a Milan and Berlin-based company developing genuinely novel and minimally-invasive implantable leads for Neuromodulation and Neuromonitoring: highly conformable, stretchable, unbreakable and cheaper to produce.
Do you want to
know more about this company?
WISE in the news
zum Artikel
Neuromodulation pioneer WISE closes EUR 15M Series C financing roundto launch second product, SCS EXPERT, for chronic pain
zum Artikel
WISE S.r.l. raises EUR 3 million for clinical development of novel neuromodulation implants for spinal cord stimulation
zum Artikel
WISE s.r.l. raises € 1 M in equity financing to Develop Next-Generation Neurostimulation Devices
More startups from Life Sciences
Treatment of sustainable plaque in coronary arteries through our proprietary catheter based device.
to Cryotherapeutics
PerformaNat GmbH was founded in 2015 as a spin-off of the veterinary medicine department of the Freie Universität Berlin. The first product – an animal-feed additive for use with dairy …
to PerformaNat
Pantherna Therapeutics is a privately-held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA …
to Pantherna Therapeutics
hema.to is an easy-to-use software for clinical decision support for blood cancer from cytometry data using AI. hema.to makes the diagnostic workflow both faster and better, helping both diagnosticians as …
to hema.to
Development of enhanced antibody-drug conjugates for improved cancer treatment
to Tubulis
Tacalyx researches and develops therapeutics targeting TACAs (tumor-associated carbohydrate antigens). These strongly tumor-specific structures are synthesized by cancer cells and contribute significantly to its virulence and metastasis. The recent possibility …
to Tacalyx
Exit
ChromoTek focuses on the discovery and development of innovative fluorescent nanoprobes derived from single-chain antibodies from Camelidae (Chromobodies) for applications in research and high-content screening.
to ChromoTek
Exit
Lipocalyx develops transfection reagents. Our Viromers® are polymers emulating a viral mechanism for cell entry. The company provides reagents and currently establishes services for pharmaceutical applications.
to Lipocalyx
DNTOX GmbH was founded in March 2022 as a spin-off from the IUF – Leibniz Institute for Environmental Medicine Research and is based on the longstanding research work of Professor …
to DNTOX
Cancilico is a Dresden-based health-tech startup founded in 2023 as a spin-off of the EKFZ for Digital Health at TUD Dresden University of Technology and University Hospital Dresden. The company …
to Cancilico
ActiTrexx GmbH is a spin-off from the University Medical Center Mainz and was founded in 2020. The company develops ATreg, a cell therapy based on activated regulatory T cells that …
to ActiTrexx
IOP GmbH will initiate a paradigm chance in glaucoma therapy by its products for telemetric, 24 hour monitoring of intraocular pressure, allowing personalized patient management.
to Implandata Ophthalmic Products